Michael D. Cameron

Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

Laura A. Solt, Yongjun Wang, Subhashis Banerjee et al. · Nature · 2012 · 803 citations · Full text

Energy Homeostasis, Sleep, Systems Biology +13

Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics

Cullen L. Schmid, Nicole Kennedy, Nicolette C. Ross et al. · Cell · 2017 · 549 citations · Full text

Opioid Epidemic, Substance Abuse, Health Sciences +14

Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation

Jang Hyun Choi, Alexander S. Banks, Theodore M. Kamenecka et al. · Nature · 2011 · 532 citations · Full text

Molecular Pharmacology, Diabetes Management, Signal Transduction +8

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

Chen Zhao, Katherine A. Cheng, Zandra E. Walton et al. · Nature · 2012 · 447 citations

Oncology, Oncogenic Agent, Medicine +9

Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis

Joanne R. Doherty, Chunying Yang, Kristen E.N. Scott et al. · Cancer Research · 2013 · 386 citations · Full text

Pathology, Metabolic Remodeling, Mct1 Inhibitors +26